253 related articles for article (PubMed ID: 27013193)
1. Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.
Gross-Cohen M; Feld S; Doweck I; Neufeld G; Hasson P; Arvatz G; Barash U; Naroditsky I; Ilan N; Vlodavsky I
Cancer Res; 2016 May; 76(9):2791-801. PubMed ID: 27013193
[TBL] [Abstract][Full Text] [Related]
2. Opposing Effects of Heparanase and Heparanase-2 in Head & Neck Cancer.
Doweck I; Feibish N
Adv Exp Med Biol; 2020; 1221():847-856. PubMed ID: 32274741
[TBL] [Abstract][Full Text] [Related]
3. Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage.
Gross-Cohen M; Feld S; Naroditsky I; Nativ O; Ilan N; Vlodavsky I
Oncotarget; 2016 Apr; 7(16):22556-65. PubMed ID: 26968815
[TBL] [Abstract][Full Text] [Related]
4. Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.
Levy-Adam F; Feld S; Cohen-Kaplan V; Shteingauz A; Gross M; Arvatz G; Naroditsky I; Ilan N; Doweck I; Vlodavsky I
J Biol Chem; 2010 Sep; 285(36):28010-9. PubMed ID: 20576607
[TBL] [Abstract][Full Text] [Related]
5. Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression.
Cohen-Kaplan V; Doweck I; Naroditsky I; Vlodavsky I; Ilan N
Cancer Res; 2008 Dec; 68(24):10077-85. PubMed ID: 19074873
[TBL] [Abstract][Full Text] [Related]
6. Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression.
Gross-Cohen M; Yanku Y; Kessler O; Barash U; Boyango I; Cid-Arregui A; Neufeld G; Ilan N; Vlodavsky I
Matrix Biol; 2021 May; 99():58-71. PubMed ID: 34004353
[TBL] [Abstract][Full Text] [Related]
7. Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3.
Knani I; Singh P; Gross-Cohen M; Aviram S; Ilan N; Sanderson RD; Aronheim A; Vlodavsky I
Matrix Biol; 2022 Jan; 105():17-30. PubMed ID: 34808335
[TBL] [Abstract][Full Text] [Related]
8. A Pro-Tumorigenic Effect of Heparanase 2 (Hpa2) in Thyroid Carcinoma Involves Its Localization to the Nuclear Membrane.
Margulis I; Naroditsky I; Gross-Cohen M; Ilan N; Vlodavsky I; Doweck I
Front Oncol; 2021; 11():645524. PubMed ID: 33959505
[TBL] [Abstract][Full Text] [Related]
9. Role of heparanase 2 (Hpa2) in gastric cancer.
Liu J; Knani I; Gross-Cohen M; Hu J; Wang S; Tang L; Ilan N; Yang S; Vlodavsky I
Neoplasia; 2021 Sep; 23(9):966-978. PubMed ID: 34343822
[TBL] [Abstract][Full Text] [Related]
10. Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival.
Doweck I; Kaplan-Cohen V; Naroditsky I; Sabo E; Ilan N; Vlodavsky I
Neoplasia; 2006 Dec; 8(12):1055-61. PubMed ID: 17217623
[TBL] [Abstract][Full Text] [Related]
11. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.
Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C
Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740
[TBL] [Abstract][Full Text] [Related]
12. Heparanase induces VEGF C and facilitates tumor lymphangiogenesis.
Cohen-Kaplan V; Naroditsky I; Zetser A; Ilan N; Vlodavsky I; Doweck I
Int J Cancer; 2008 Dec; 123(11):2566-73. PubMed ID: 18798279
[TBL] [Abstract][Full Text] [Related]
13. Impact of heparanase-2 (Hpa2) on cancer and inflammation: Advances and paradigms.
Vlodavsky I; Hilwi M; Kayal Y; Soboh S; Ilan N
FASEB J; 2024 May; 38(10):e23670. PubMed ID: 38747803
[TBL] [Abstract][Full Text] [Related]
14. Heparanase promotes glioma progression via enhancing CD24 expression.
Barash U; Spyrou A; Liu P; Vlodavsky E; Zhu C; Luo J; Su D; Ilan N; Forsberg-Nilsson K; Vlodavsky I; Yang X
Int J Cancer; 2019 Sep; 145(6):1596-1608. PubMed ID: 31032901
[TBL] [Abstract][Full Text] [Related]
15. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
16. Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2.
Gross-Cohen M; Feld S; Arvatz G; Ilan N; Vlodavsky I
Front Oncol; 2020; 10():627463. PubMed ID: 33585253
[TBL] [Abstract][Full Text] [Related]
17. High heparanase activity in multiple myeloma is associated with elevated microvessel density.
Kelly T; Miao HQ; Yang Y; Navarro E; Kussie P; Huang Y; MacLeod V; Casciano J; Joseph L; Zhan F; Zangari M; Barlogie B; Shaughnessy J; Sanderson RD
Cancer Res; 2003 Dec; 63(24):8749-56. PubMed ID: 14695190
[TBL] [Abstract][Full Text] [Related]
18. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
19. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
20. Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma.
Hirshoren N; Bulvik R; Neuman T; Rubinstein AM; Meirovitz A; Elkin M
J Cell Mol Med; 2014 Jan; 18(1):181-6. PubMed ID: 24286246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
